Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction
Active, not recruiting · NCT06576921 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Phase 2 | 2026-09-10 | NCT06576921 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Digestive surgery, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi' an, China | Xi'an | China | 1 |
| Department of General Surgery, Tangdu Hospital, Air Force Medical University | Xi'an | China | 1 |
| Department of General Surgery, The 986th Military Hospital, Air Force Medical University | Xi'an | China | 1 |
| The fourth hospital of Hebei Medical University | Shijiazhuang | China | 1 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 18 |